Get started free →
HRES 1365 119th Congress · House

House Resolution on ARFID Awareness and Care

Advocate

Official title: Recognizing Avoidant/Restrictive Food Intake Disorder (ARFID) as a serious feeding and eating disorder and acknowledging the urgent need to advance awareness, early identification, research, and equitable access to care.

This House resolution recognizes Avoidant/Restrictive Food Intake Disorder (ARFID) as a serious feeding and eating disorder and calls attention to the need for better awareness, earlier identification, research, and equitable access to care. It is aimed at patients, families, clinicians, schools, and health systems that encounter ARFID but may not recognize it quickly enough. The resolution does not create a new benefit or payment program; instead, it uses the House’s platform to elevate the issue and encourage action across the health and education systems.

  • Recognizes ARFID as a serious feeding and eating disorder.
  • Calls for greater awareness and early identification of the condition.
  • Highlights the need for more research on ARFID.
  • Supports equitable access to care for affected patients and families.
Public Relevance 22 / 100
Niche Modest scope Broad

For people with ARFID, their families, and the clinicians or schools that support them, this resolution could help increase recognition of the disorder and encourage earlier identification and better referral pathways. It may also strengthen the case for more research and more equitable access to specialized care, but it does not itself create a new federal benefit, mandate, or funding stream.

See how this bill affects you — sign in for a personalized analysis
FOR
  • Patients and families affected by ARFID They want the disorder taken seriously so symptoms are recognized earlier and treatment starts sooner. Formal congressional recognition can reduce stigma and help families navigate schools, doctors, and insurers.
  • Pediatric and mental health clinicians Providers often need clearer public and institutional recognition to improve screening, diagnosis, and referral. A resolution can support better training and more consistent standards of care.
  • Researchers in eating disorders and child health Public recognition can help elevate ARFID in research agendas and attract attention to gaps in evidence. That can improve understanding of causes, prevalence, and effective treatments.
AGAINST
  • Fiscal conservatives concerned about symbolic legislation They may argue that a resolution does not directly deliver services or measurable outcomes and can distract from legislation that funds treatment or research. Their concern is that congressional attention should focus on concrete program changes.
  • Health policy skeptics of federal messaging resolutions They may view the measure as duplicative of existing medical and public health efforts. In their view, awareness campaigns are best handled by professional societies, schools, and agencies rather than Congress.
  • Insurers and cost-conscious payers If the resolution leads to pressure for broader screening, specialist referrals, or coverage changes, payers may worry about higher utilization and costs. They may prefer clearer evidence and targeted standards before any broader mandates.
  • “Recognizing Avoidant/Restrictive Food Intake Disorder (ARFID) as a serious feeding and eating disorder”

    This language places ARFID in the category of clinically serious disorders rather than a behavioral preference or minor eating issue. In practice, that can influence how schools, doctors, and families interpret symptoms and whether they seek formal evaluation.

  • “advance awareness, early identification”

    The resolution points toward screening and earlier diagnosis, especially in pediatric and primary care settings. Earlier identification can reduce delays in treatment and help prevent nutritional and developmental complications.

  • “research”

    This signals congressional support for expanding the evidence base on ARFID, including causes, prevalence, and treatment approaches. More research can eventually shape clinical guidelines and insurance coverage decisions.

  • “equitable access to care”

    This emphasizes that treatment should not depend on geography, income, or insurance status. It highlights the real-world gap between recognizing a disorder and actually being able to see a qualified specialist.

June 11, 2026

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Take Action

Get more from BillBoard

Free tools to understand, respond to, and track this bill.

Ask AI about this bill

Data sourced from api.congress.gov.

Free to use · No credit card

Understand every bill.
Make your voice count.

BillBoard turns dense U.S. legislation into plain-English summaries, helps you take a stance, and connects you to your representatives — in seconds.